Chiarodo A. National Cancer Institute roundtable on prostate cancer: Future research directions. Cancer Res 1991; 51: 2498–505.
National Cancer Institute. Cancer Statistics Review 1973–1987. Bethesda, MD (USA) Division of Cancer Prevention and Control, 1990; DHHS Pub. No. NIH 90–2789.
Muir CS, Nectous J, Staszewski J. The epidemiology of prostatic cancer. Geographic distribution and timetrends. Acta Oncol 1991; 30: 133–40.
Department de Salud. Cancer en Puerto Rico 1991. San Juan, Puerto Rico: Department de Calud, 1993.
Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994; 243: 251–4.
Waterhouse J, Muir C, Correa P, Powell J. Cancer Incidence In Five Continents, Vol. III. Lyon, France: International Agency for Research on Cancer, 1976; IARC Pub. No. 15.
Waterhouse J, Muir C, Shanmugaratnam K, Powell J. Cancer Incidence in Five Continents, Vol, IV. Lyon, France: International Agency for Research on Cancer, 1982; IARC Sci. Pub. No. 42.
Muir C, Waterhouse J, Mack T, Powell J, Whelen S. Cancer Incidence In Five Continents, Vol. V. Lyon, France: International Agency for Research on Cancer, 1987; IARC Sci. Pub. No. 88.
Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection. JNCI 1990; 82: 1624–8.
Hanks GE, Myers CE, Scardino PT. Cancer of the prostate. In: De Vita VTJr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, Fourth Edition. Philadelphia, PA (USA): J.B. Lippincott Co, 1993; 1073–108.
Gilliland FD, Becker TM, Key CR, Samet JM. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks. Cancer 1994; 73: 2192–9.
Natarajan N, Murphy GP, Mettlin C. Prostate cancer in Blacks: an update from the American College of Surgeons' Pattern of Care Studies. J Surg Oncol 1989; 40: 232–6.
Levine MS, Arger PH, Coleman BG, Mulhern CBJr, Pollack HM, Wein AJ. Detecting lymphatic metastases from prostatic carcinoma: superiority of CT. Am J Roentgen 1981; 137: 207–11.
Schaffer D, Pendergrass HP. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 1976; 121: 431–4.
Murphy GP, Natarajan JE, Pontes JE, et al. The national survey of prostate cancer in the United States by the American College of Surgeons. J Urology 1982; 127: 928–34.
Thompson IM, Rounder JB, Teague JL, Peek M, Spence CR. Impact of routine screening for adenocarcinoma of the prostate on stage distribution. J Urology 1987; 137: 424–6.
Garnick MB. Prostate cancer: screening, diagnosis and management. Ann Int Med 1993; 118: 804–18.
Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut. Cancer 1992; 70: 2152–8.
Austin JP, Aziz H, Potters L, et al. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol 1990; 13: 465–9.
Meikle AW, Smith JAJr, Epidemiology of prostate cancer. Urol Clin N Amer 1990; 17: 709–18.
Mack TM. Cancer Surveillance Program in Los Angeles County. Natl Cancer Inst Monogr 1977; 47: 99–101.
Hollingshead AB, Redlich FC. Social Class and Mental Illness. New York, NY (USA): Wiley, 1958.
Breslow NE, Day NE. Statistical Methods in Cancer Research: Vol. II. The Design and Analysis of Cobort Studies. Lyon, France: International Agency for Research on Cancer, 1987: IARC Sci. Pub. No. 82: 120–37.
Menck HR, Henderson BE, Pike MC, Mack T, Martin SP, SooHoo J. Cancer incidence in the Mexican-American JNCI 1975; 55: 531–6.
Sidney S, Quesenberry CPJr, Sadler MC, Guess HA, Lydick EG, Cattolica EV. Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol 1991; 134: 825–9.